相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transforming Healthcare Delivery: Integrating Dynamic Simulation Modelling and Big Data in Health Economics and Outcomes Research
Deborah A. Marshall et al.
PHARMACOECONOMICS (2016)
The potential of genetically guided treatment in Behcet's disease
Tamer A. Gheita et al.
PHARMACOGENOMICS (2016)
Cost-effectiveness modelling in diagnostic imaging: a stepwise approach
Anna M. Sailer et al.
EUROPEAN RADIOLOGY (2015)
Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?
Mark Lawler et al.
PUBLIC HEALTH GENOMICS (2015)
Getting Personal: Accelerating Personalised and Precision Medicine Integration into Clinical Cancer Research and Care in Clinical Trials
Denis Horgan et al.
PUBLIC HEALTH GENOMICS (2015)
Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions
William H. Crown
VALUE IN HEALTH (2015)
Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research-The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force
Deborah A. Marshall et al.
VALUE IN HEALTH (2015)
Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force
Deborah A. Marshall et al.
VALUE IN HEALTH (2015)
Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects
C. L. M. Krieckaert et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The use of clinical and biological characteristics to predict outcome following First Episode Psychosis
K. Oliver Schubert et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
Aggregate Cost of Mammography Screening in the United States: Comparison of Current Practice and Advocated Guidelines
Cristina O'Donoghue et al.
ANNALS OF INTERNAL MEDICINE (2014)
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
C. M. Booth et al.
BRITISH JOURNAL OF CANCER (2014)
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
Salvatore Petta et al.
DIGESTIVE AND LIVER DISEASE (2014)
Agent-based model of fecal microbial transplant effect on bile acid metabolism on suppressing Clostridium difficile infection: an example of agent-based modeling of intestinal bacterial infection
Xavier Peer et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy
Taewoo Lee et al.
KIDNEY INTERNATIONAL (2014)
Prognostic and Predictive Biomarkers: Tools in Personalized Oncology
Ewelina Nalejska et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
A systems science approach to fatigue management in research and health care
Kathryn A. Lee et al.
NURSING OUTLOOK (2014)
Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
Ester Vilaprinyo et al.
PLOS ONE (2014)
Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?
Janine A. van Til et al.
PHARMACOECONOMICS (2014)
Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making
Anders Chen et al.
PLOS ONE (2014)
Economic Utility of a Blood-Based Genomic Test for the Assessment of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease
Louis I. Hochheiser et al.
POPULATION HEALTH MANAGEMENT (2014)
What is personalized medicine: sharpening a vague term based on a systematic literature review
Sebastian Schleidgen et al.
BMC MEDICAL ETHICS (2013)
Using grounded theory as a method for rigorously reviewing literature
Joost F. Wolfswinkel et al.
EUROPEAN JOURNAL OF INFORMATION SYSTEMS (2013)
Modeling the Effectiveness of Initial Management Strategies for Ductal Carcinoma In Situ
Djra I. Soeteman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
An economic model to value companion diagnostics in non-small-cell lung cancer
Robert D. Lieberthal et al.
PERSONALIZED MEDICINE (2013)
The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid Leukemia
Annemieke Leunis et al.
PHARMACOECONOMICS (2013)
Current Methodological Issues in the Economic Assessment of Personalized Medicine
Lieven Annemans et al.
VALUE IN HEALTH (2013)
Economic Incentives for Evidence Generation: Promoting an Efficient Path to Personalized Medicine
Adrian Towse et al.
VALUE IN HEALTH (2013)
Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
Olga Golubnitschaja et al.
EPMA JOURNAL (2013)
The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop
Carla Guerriero et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2013)
The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in US Primary Care Settings
David B. Rein et al.
ANNALS OF INTERNAL MEDICINE (2012)
Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years A Comparative Modeling Study of Risk
Nicolien T. van Ravesteyn et al.
ANNALS OF INTERNAL MEDICINE (2012)
The Cost-Effectiveness of Preexposure Prophylaxis for HIV Prevention in the United States in Men Who Have Sex With Men
Jessie L. Juusola et al.
ANNALS OF INTERNAL MEDICINE (2012)
Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
Gilberto de Lima Lopes et al.
CANCER (2012)
A Risk-Benefit Assessment of Prasugrel, Clopidogrel, and Genotype-Guided Therapy in Patients Undergoing Percutaneous Coronary Intervention
G. F. Guzauskas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare
Lavinia Ferrante di Ruffano et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Comparative Effectiveness Research, Genomics-Enabled Personalized Medicine, and Rapid Learning Health Care: A Common Bond
Geoffrey S. Ginsburg et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Genetic Testing in Combination with Preventive Donepezil Treatment for Patients with Amnestic Mild Cognitive Impairment An Exploratory Economic Evaluation of Personalized Medicine
Sandjar Djalalov et al.
MOLECULAR DIAGNOSIS & THERAPY (2012)
OR Forum-A POMDP Approach to Personalize Mammography Screening Decisions
Turgay Ayer et al.
OPERATIONS RESEARCH (2012)
Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
Jonathan Karnon et al.
VALUE IN HEALTH (2012)
Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study
Bart S. Ferket et al.
PLOS MEDICINE (2012)
Cost Effectiveness of Personalized Therapy for First-Line Treatment of Stage IV and Recurrent Incurable Adenocarcinoma of the Lung
Elizabeth A. Handorf et al.
JOURNAL OF ONCOLOGY PRACTICE (2012)
Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness
John T. Schousboe et al.
ANNALS OF INTERNAL MEDICINE (2011)
Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost-Effectiveness Analysis
Uri Ladabaum et al.
ANNALS OF INTERNAL MEDICINE (2011)
A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
Saiko Kurosawa et al.
BLOOD (2011)
Cost-effectiveness of early detection of breast cancer in Catalonia (Spain)
Misericordia Carles et al.
BMC CANCER (2011)
The Cost-Effectiveness of Personalized Genetic Medicine The case of genetic testing in neonatal diabetes
Siri Atma W. Greeley et al.
DIABETES CARE (2011)
Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
Shan Liu et al.
PLOS ONE (2011)
Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysis
Maarten J. Postma et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score
Sean D. Sullivan et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Do Economic Evaluations of Targeted Therapy Provide Support for Decision Makers?
Ilia L. Ferrusi et al.
JOURNAL OF ONCOLOGY PRACTICE (2011)
Determining cost-effectiveness of advanced cancer care: a systematic review of economic models
C. Hulme et al.
BMJ Supportive & Palliative Care (2011)
Health economic effect of donepezil treatment for CDR 0.5 converters to Alzheimer's disease as shown by the Markov model
Masashi Kasuya et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2010)
The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
Mercy Mvundura et al.
GENETICS IN MEDICINE (2010)
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia
Daoud Al-Badriyeh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Uncertainty in Assessing Value of Oncology Treatments
C. Daniel Mullins et al.
ONCOLOGIST (2010)
Systematic review of pharmacoeconomic studies of pharmacogenomic tests
Mathieu Beaulieu et al.
PHARMACOGENOMICS (2010)
A systematic review of cost effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives
Talitha I. Verhoef et al.
PHARMACOGENOMICS (2010)
Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
Mark H. Eckman et al.
ANNALS OF INTERNAL MEDICINE (2009)
HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-Effectiveness
A. David Paltiel et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Outcomes and Cost-Effectiveness of Coronary Computed Tomography Angiography in the Evaluation of Patients With Chest Pain
Joseph A. Ladapo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
Roy H. Perlis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness
Kamal Desai et al.
AIDS (2008)
Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective
T. Kobayashi et al.
EJSO (2007)
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
WH Herman et al.
ANNALS OF INTERNAL MEDICINE (2005)
Cost effectiveness of a new strategy to identify HNPCC patients
W Kievit et al.
GUT (2005)
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes:: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
CS Cutler et al.
BLOOD (2004)
A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
KA Phillips et al.
PHARMACOGENOMICS (2004)
An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer
SD Ramsey et al.
GENETICS IN MEDICINE (2003)
Treatment options for patients with acute myeloid leukemia with a matched sibling donor - A decision analysis
L Sung et al.
CANCER (2003)
Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma - Effectiveness and cost-effectiveness
CM Reyes et al.
CANCER (2002)
分享论文
